LEP and obesity due to melanocortin 4 receptor deficiency: In addition to its antifibrotic effects, the treatment with BAPN was able to prevent the increase in O2- production observed in the aorta of the obese animals, as well as in VSMCs treated with leptin, a hormone upregulated in obesity which is involved in the vascular fibrosis observed in obese rats [35].